Results 321 to 330 of about 519,424 (339)
Some of the next articles are maybe not open access.

T-Cell Lymphoma

2019
T-cell lymphomas of the ocular adnexa are extremely rare and when present may be a manifestation of known preexisting systemic disease. They arise primarily from the paranasal sinuses, more commonly in East Asians. While B-cell lymphomas are usually well recognized and more easily treated, T-cell lymphomas often carry a guarded prognosis.
Poh Sun Goh   +5 more
openaire   +2 more sources

T-Cell Lymphomas

2013
* Classification of the T-cell lymphomas * Epidemiology, prognosis and outcomes for aggressive T-cell lymphomas - * Molecular pathogenesis of T-cell lymphoma- * HTLV-1 associated T-cell diseases- * The NK/T cell lymphomas- * CD30 positive T-cell lymphomas- * Extranodal T-cell lymphomas * Nodal T-cell lymphomas * The T-cell leukemias * Chemotherapy and ...
Julie M. Vose, Basem M. William
openaire   +4 more sources

T-Cell Lymphoma

2011
A 51-year-old female came to the dermatology clinic with a 20 year history of a rash on her trunk and inner arms that had previously been diagnosed as chronic dermatitis. Physical exam revealed that approximately 10% of her body surface was involved by red to brown scaly patches. No lymphadenopathy or hepatosplenomegaly was present.
Janina A. Longtine, Marian H. Harris
openaire   +2 more sources

Mantle cell lymphoma

Current Opinion in Hematology, 2004
Mantle cell lymphoma is the B-cell lymphoma with the worst prognosis. Until now, no standard treatment has resulted in cure. Improvements in understanding of the disease are needed to advance therapeutic efforts.Pathology and immunohistochemistry can identify the subset of patients with the worse prognosis.
Emanuele Zucca   +2 more
openaire   +3 more sources

T-Cell Lymphoma

2004
The T-cell lymphomas make up a heterogeneous group of aggressive neoplasms that share a T-cell immunophenotype. Although some of the diseases in T-cell lymphomas may have a protracted clinical course, the majority are the most aggressive hematopoietic and lymphoid neoplasms.
Byung Ihn Choi, Hyun Ju Lee
openaire   +2 more sources

T-Cell Lymphomas

2016
Mature T-cell and natural killer (NK)-cell neoplasms account for a small proportion of non-Hodgkin lymphomas (NHL). Despite the fact that they are relatively uncommon, T-cell lymphoproliferations often are submitted to the clinical molecular laboratory for testing.
Daniel A. Arber, Jason D. Merker
openaire   +2 more sources

Peripheral T-cell Lymphomas

2019
Peripheral T-cell lymphomas (PTCLs) account for about 12% of all lymphoid neoplasms in Western Countries. They show an endemic prevalence in some geographic areas, including southern Japan, Caribbean Basin, and regions of Mexico and USA, where they are related to HTVL1 infection.1 PTCLs can be roughly subdivided into specified and not otherwise ...
PILERI, STEFANO   +6 more
openaire   +3 more sources

NK-Cell Lymphomas

2018
NK-cell malignancies are rare aggressive diseases associated with poor clinical outcome. There is a significant geographic variation in their incidence. At least a part of the reason for that is the fact that Epstein-Barr virus plays an important role in pathogenesis, and importantly, the plasma viral titer reflects disease burden and response to ...
Yasuhiro Oki, Dai Chihara
openaire   +3 more sources

Cutaneous T-cell lymphomas

Seminars in Oncology Nursing, 1998
To describe the current state of the knowledge regarding the pathology, clinical presentation, treatment strategies, and nursing management of patients with cutaneous T-cell lymphoma, specifically, mycosis fungoides and the Sezary syndrome.Book chapters, review articles, published research studies, proceedings from professional meetings.Although ...
openaire   +3 more sources

T-cell lymphoma

Best Practice & Research Clinical Haematology, 2013
Catherine Lai, Wyndham H. Wilson
openaire   +2 more sources

Home - About - Disclaimer - Privacy